Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBC vs Standard Care for MDD
NCT02191124Phase 4Completed
- Sponsor
- Capital Medical University
- Start
- Jun 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine, mirtazapine in major depressive disorder (MDD), sponsored by Capital Medical University. Started Jun 2011; status: completed.
02
Drugs
paroxetinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02191124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191124.